This inventor holds 1 USPTO granted patent. Top assignee: Ever Supreme Bio Technology Co. Ltd. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Chia-Ing Jan: Innovator in Cancer Treatment
Introduction
Chia-Ing Jan is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative cancer treatments. His work focuses on creating advanced therapeutic solutions that can improve patient outcomes.
Latest Patents
Chia-Ing Jan holds a patent for "Multispecific Single Domain Antibodies Chimeric Antigen Receptor and T-Cell Engager, Nucleic Acid, Expressing Cell Thereof, Pharmaceutical Composition for Treating Cancer, and Method for Inhibiting Proliferation of Tumor Cell." This patent highlights his commitment to advancing cancer therapies through innovative approaches.
Career Highlights
Throughout his career, Chia-Ing Jan has been associated with Ever Supreme Bio Technology Co. Ltd., where he has played a crucial role in research and development. His expertise in biotechnology has positioned him as a key figure in the industry, contributing to the advancement of cancer treatment methodologies.
Collaborations
Chia-Ing Jan has collaborated with notable colleagues, including Shao-Chih Chiu and Shi-Wei Huang. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking innovations in cancer therapy.
Conclusion
Chia-Ing Jan's contributions to biotechnology and cancer treatment exemplify the impact of innovative thinking in the medical field. His work continues to inspire advancements that hold the potential to change lives for the better.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile